FDA Inspection 1302186 - Grifols Therapeutics LLC - February 05, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Grifols Therapeutics LLC

Record Details

This FDA Inspection record concerns Grifols Therapeutics LLC, with an inspection on February 5, 2026, issued by the Atlanta District Office, covering biologics.

Company: Grifols Therapeutics LLC
Inspection Date: February 5, 2026
Product Type: Biologics
Office: Atlanta District Office

Open in Dashboard

ID · 34708a56-41e8-4e87-bab0-c702d71a2713

Violation Codes3

21 CFR 211.100(b)21 CFR 211.19221 CFR 600.80(c)(1)(i)

Full citation text and observation details available on the Dashboard.